Based on the observed OPG down-regulation in CRC cell lines and the identification of promoter hypermethylation as one of the causes for this down-regulation, we propose that the methylation status of the OPG promoter should be analyzed for cancers of various organs with confirmatory reports of OPG expression. Here, TNFRSF11B is linked to cancer.